Multiple Myeloma: International Myeloma Foundation : ASH 2011: Dr. Leleu - Final Analysis of MELISSE, a Large Multicentric Observational Study to Determine Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Treated with Immunomodulator Drugs

back

ASH 2011: Dr. Leleu - Final Analysis of MELISSE, a Large Multicentric Observational Study to Determine Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Treated with Immunomodulator Drugs

Xavier Leleu, MD, PhD
Hopital Claude Huriez
CHRU
Lille, France

	12.06.11
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share \| related articles

Be the first to comment